Corellia AI
Corellia AI accelerates oncology drug discovery using AI and a deep cancer dataset. It uses AI-enabled workflows across research platforms and advanced experimental capabilities. Launched in 2023 from Champions Oncology, the company builds first-in-class therapeutics through a data-driven ecosystem. Its drug-conjugate programs include CO-1024 for solid tumors and CO-1008 for hematologic cancers, with clinical progress targeted by 2026. Corellia AI partners with biopharma and technology firms to scale transformative oncology programs.
Corellia AI
Corellia AI accelerates oncology drug discovery using AI and a deep cancer dataset. It uses AI-enabled workflows across research platforms and advanced experimental capabilities. Launched in 2023 from Champions Oncology, the company builds first-in-class therapeutics through a data-driven ecosystem. Its drug-conjugate programs include CO-1024 for solid tumors and CO-1008 for hematologic cancers, with clinical progress targeted by 2026. Corellia AI partners with biopharma and technology firms to scale transformative oncology programs.